Gate 322 Lofibra 67 mg Pill - pink capsule/oblong, 14mm

Generic Name: fenofibrate

Pill with imprint Gate 322 Lofibra 67 mg is Pink, Capsule/Oblong and has been identified as Lofibra 67 mg. It is supplied by Gate Pharmaceuticals.

Lofibra is used in the treatment of Hypertriglyceridemia; Hyperlipoproteinemia Type IIa, Elevated LDL; Hyperlipoproteinemia; Hyperlipoproteinemia Type IV, Elevated VLDL; Hyperlipoproteinemia Type IIb, Elevated LDL VLDL and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 67 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Gate 322 Lofibra 67 mg

Lofibra

Generic Name: fenofibrate
Imprint: Gate 322 Lofibra 67 mg
Strength: 67 mg
Color: Pink
Size: 14.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Fibric acid derivatives
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Gate Pharmaceuticals
National Drug Code (NDC): 57844-0322 (Discontinued)
Inactive Ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone k25, corn starch, sodium lauryl sulfate, magnesium silicate, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, titanium dioxide
Note: Inactive ingredients may vary.